GM9
2-[3-[[(4-~{tert}-butylphenyl)methyl-pyridin-3-ylsulfonyl-amino]methyl]phenoxy]ethanoic acid
Find entries where: GM9
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 2-[3-[[(4-~{tert}-butylphenyl)methyl-pyridin-3-ylsulfonyl-amino]methyl]phenoxy]ethanoic acid |
Identifiers | 2-[3-[[(4-~{tert}-butylphenyl)methyl-pyridin-3-ylsulfonyl-amino]methyl]phenoxy]ethanoic acid |
Formula | C25 H28 N2 O5 S |
Molecular Weight | 468.565 |
Type | NON-POLYMER |
Isomeric SMILES | CC(C)(C)c1ccc(cc1)CN(Cc2cccc(c2)OCC(=O)O)S(=O)(=O)c3cccnc3 |
InChI | InChI=1S/C25H28N2O5S/c1-25(2,3)21-11-9-19(10-12-21)16-27(33(30,31)23-8-5-13-26-15-23)17-20-6-4-7-22(14-20)32-18-24(28)29/h4-15H,16-18H2,1-3H3,(H,28,29) |
InChIKey | WOHRHWDYFNWPNG-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 61 |
Chiral Atom Count | 0 |
Bond Count | 63 |
Aromatic Bond Count | 18 |
Drug Info: DrugBank
DrugBank ID | DB12022 |
---|---|
Name | Evatanepag |
Groups | investigational |
Description | Evatanepag has been used in trials studying the treatment of Tibial Fractures. |
Synonyms |
|
CAS number | 223488-57-1 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL563646 |
PubChem | 9890801 |
ChEMBL | CHEMBL563646 |